From: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
Multi (n = 25) | Single (n = 15) | p-value | |
---|---|---|---|
Initial escalation day | |||
Reactions (Reaction rate) | 15 (60%) | 6 (40%) | .22 |
Epinephrine use | 0 | 0 | 1.00 |
Dose escalations | |||
Total doses | 603 doses | 277 doses | |
Median reaction rate [range] | 3.4% [0–23.1] | 3.7% [0–16.6] | .31 |
Epinephrine use | 0 | 0 | 1.00 |
Home dosing | |||
Total doses | 12030 doses | 7830 doses | |
Median reaction rate [range] | 3.1% [0.6-29.2] | 2.9% [0.1-59.0] | .65 |
Epinephrine use (per dose) | 2 (0.02%) | 2 (0.03%) | .67 |
Epinephrine use (per participant) | 2 (8%) | 2 (13%) | .62 |